Late stimulation of the sphenopalatine-ganglion in ischemic rats: Improvement in N-acetyl-aspartate levels and diffusion weighted imaging characteristics as seen by MR

Journal of Magnetic Resonance Imaging

Volumn 31, Issue 6, 2010, Pages 1355-1363

  Bar Shir, Amnon ^a   Shemesh, Noam ^a   Nossin Manor, Revital ^a,b   Cohen, Yoram ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Middle cerebral artery occlusion (MCAO); MR spectroscopy (MRS); MRI; N acetyl aspartate (NAA); Sphenopalatine ganglion (SPG)

Indexed keywords

N ACETYLASPARTIC ACID; ASPARTIC ACID; N-ACETYLASPARTATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN REGION; BRAIN TISSUE; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; ELECTROSTIMULATION; GANGLION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PTERYGOPALATINE GANGLION; RAT; STROKE; ANALOGS AND DERIVATIVES; ANIMAL; BRAIN; CEREBRAL ARTERY DISEASE; ELECTRODE; ELECTROSTIMULATION THERAPY; METABOLISM; PATHOLOGY; PROCEDURES; TIME; WISTAR RAT;

ANIMALS; ASPARTIC ACID; BRAIN; BRAIN ISCHEMIA; DIFFUSION MAGNETIC RESONANCE IMAGING; ELECTRIC STIMULATION THERAPY; ELECTRODES; GANGLIA; INFARCTION, MIDDLE CEREBRAL ARTERY; MAGNETIC RESONANCE SPECTROSCOPY; MALE; RATS; RATS, WISTAR; TIME FACTORS;

EID: 77952804323     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22110     Document Type: Article

References (40)

1. American Heart Association: Heart disease and stroke statistics - 2005 update. Dallas, Texas: American Heart Association; 2005.
2. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 1997;349:1269-1276. (Pubitemid 27192468)
3. Feigin VL, Lawes CMM, Bennett DA, Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2003;2:43-53.
4. Moustafa RR, Baron JC. Clinical review: imaging in ischaemic stroke - implications for acute management. Crit Care 2007;11:1-9.
5. Fisher M, Bastan B. Treating acute ischemic stroke. Curr Opin Drug Discov Devel 2008;11:626-632.
6. Smith WS, Sung G, Starkman S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke- results of the MERCI trial. Stroke 2005;36:1432-1438. (Pubitemid 40967507)
7. Cramer SC, Koroshetz WJ, Finklestein SP. The case for modality-specific outcome measures in clinical trials of stroke recovery-promoting agents. Stroke 2007;38:1393-1395.
8. Ayajiki K, Fujioka H, Shinozaki K, Okamura T. Effects of capsaicin and nitric oxide synthase inhibitor on increase in cerebral blood flow induced by sensory and parasympathetic nerve stimulation in the rat. J Appl Physiol 2005;98:1792-1798. (Pubitemid 40570791)
9. Suzuki N, Hardebo JE, Kahrstrom J, Owman C. Selective electrical-stimulation of postganglionic cerebrovascular parasympathetic nerve fibers originating from the Sphenopalatine Ganglion enhances cortical blood-flow in the rat. J Cereb Blood Flow Metab 1990;10:383-391. (Pubitemid 20144618)
10. Yarnitsky D, Lorian A, Shalev A, et al. Reversal of cerebral vasospasm by sphenopalatine ganglion stimulation in a dog model of subarachnoid hemorrhage. Surg Neurol 2005;64:5-11. (Pubitemid 40916952)
11. Uddman R, Tajti J, Moller S, Sundler F, Edvinsson L. Neuronal messengers and peptide receptors in the human sphenopalatine and otic ganglia. Brain Res 1999;826:193-199. (Pubitemid 29222933)
12. Suzuki N, Hardebo JE, Kahrstrom J, Owman C. Neuropeptide-y coexists with vasoactive intestinal polypeptide and acetylcholine in parasympathetic cerebrovascular nerves originating in the sphenopalatine, otic, and internal carotid ganglia of the rat. Neuroscience 1990;36:507-519. (Pubitemid 20247114)
13. Suzuki N, Hardebo JE. The cerebrovascular parasympathetic innervation. Cerebrovasc Brain Metab Rev 1993;5:33-46.
14. Kano M, Moskowitz MA, Yokota M. Parasympathetic denervation of rat pial vessels significantly increases infarction volume following middle cerebral artery occlusion. J Cereb Blood Flow Metab 1991;11:628-637.
15. Koketsu N, Moskowitz MA, Kontos HA, Yokota M, Shimizu T. Chronic parasympathetic sectioning decreases regional cerebral blood-flow during hemorrhagic hypotension and increases infarct size after middle cerebral-artery occlusion in spontaneously hypertensive rats. J Cereb Blood Flow Metab 1992;12:613-620.
16. Henninger N, Fisher M. Stimulating circle of Willis nerve fibers preserves the diffusion-perfusion mismatch in experimental stroke. Stroke 2007;38:2779-2786. (Pubitemid 47494018)
17. Moseley ME, Cohen Y, Mintorovitch J, et al. Early detection of regional cerebral ischemia in cats- comparison of diffusion weighted and T2-weighted MRI and Spectroscopy. Magn Reson Med 1990;14:330-346. (Pubitemid 20248617)
18. Hoehn M, Nicolay K, Franke C, van der Sanden B. Application of magnetic resonance to animal models of cerebral ischemia. J Magn Reson Imaging 2001;14:491-509. (Pubitemid 33029535)
19. Mikulis DJ, Roberts TPL. Neuro MR: protocols. J Magn Reson Imaging 2007;26:838-847.
20. Back T. Hemmen T, Schuler OG. Lesion evolution in cerebral ischemia. J Neurol 2004;251:388-397.
21. Sotak CH. Nuclear magnetic resonance (NMR) measurement of the apparent diffusion coefficient (ADC) of tissue water and its relationship to cell volume changes in pathological states. Neurochem Int 2004;45:569-582.
22. Nagesh V, Welch KMA, Windham JP, et al. Time course of ADC(w) changes in ischemic stroke: beyond the human eye! Stroke 1998;29:1778-1782.
23. Ulug AM, Beauchamp N, Bryan RN, van Zijl PCM. Absolute quantitation of diffusion constants in human stroke. Stroke 1997;28:483-490.
24. Li FH, Han SS, Tatlisumak T, et al. Reversal of acute apparent diffusion coefficient abnormalities and delayed neuronal death following transient focal cerebral ischemia in rats. Ann Neurol 1999;46:333-342. (Pubitemid 29416271)
25. Wardlaw JM, Marshall I, Wild J, Dennis MS, Cannon J, Lewis SC. Studies of acute ischemic stroke with proton magnetic resonance spectroscopy - relation between time from onset, neurological deficit, metabolite abnormalities in the infarct, blood flow, and clinical outcome. Stroke 1998;29:1618-1624. (Pubitemid 28365584)
26. Igarashi H, Kwee IL, Nakada T, Katayama Y, Terashi A. 1H magnetic resonance spectroscopic imaging of permanent focal cerebral ischemia in rat: longitudinal metabolic changes in ischemic core and rim. Brain Res 2001;907:208-221. (Pubitemid 32595530)
27. Demougeot C, Garnier P, Mossiat C, et al. N-Acetyl-aspartate, a marker of both cellular dysfunction and neuronal loss: its relevance to studies of acute brain injury. J Neurochem 2001;77:408-415. (Pubitemid 32298735)
28. Demougeot C, Bertrand N, Prigent-Tessier A, et al. Reversible loss of N-acetyl-aspartate in rats subjected to long-term focal cerebral ischemia. J Cereb Blood Flow Metab 2003;23:482-489. (Pubitemid 36403030)
29. 1H-MR spectroscopy study. Neuroradiology 1997;39:560-565.
30. Parsons MW, Li T, Barber PA, et al. Combined 1H MR spectroscopy and diffusion-weighted MRI improves the prediction of stroke outcome. Neurology 2000;55:498-505. (Pubitemid 30647244)
31. Demougeot C, Marie C, Giroud M, Beley A. N-Acetyl-aspartate: a literature review of animal research on brain ischaemia. J Neurochem 2004;90:776-783. (Pubitemid 39099958)
32. Spratt NJ, Fernandez J, Chen M, et al. Modification of the method of thread manufacture improves stroke induction rate and reduces mortality after thread-occlusion of the middle cerebral artery in young or aged rats. J Neurosci Methods 2006;155:285-290. (Pubitemid 44233014)
33. Cobas JC, Sardina FJ. Nuclear magnetic resonance data processing. MestRe-C: a software package for desktop computers. Concepts Magn Reson Part A 2003;19:80-96.
34. Chen JL, Li Y, Wang L, et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 2001;32:1005-1011. (Pubitemid 32285175)
35. Moffett JR, Namboodiri MAA, Cangro CB, Neale JH. Immunohistochemical localization of N-Acetyl-aspartate in rat brain. Neuroreport 1991;2:131-134.
36. Bruhn H, Frahm J, Gyngell ML, Merboldt KD, Hanicke W, Sauter R. Cerebral metabolism in man after acute stroke - new observations using localized proton NMR-spectroscopy. Magn Reson Med 1989;9:126-131. (Pubitemid 19044566)
37. Sager TN, Laursen H, Hansen AJ. Changes in N-Acetyl-aspartate content during focal and global brain ischemia of the rat. J Cereb Blood Flow Metab 1995;15:639-646.
38. Moffett JR, Ross B, Arun P, Madhavarao CN, Namboodiri AMA. N-Acetyl-aspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol 2007;81:89-131.
39. Clark JB. N-acetyl-aspartate: a marker for neuronal loss or mitochondrial dysfunction. Dev Neurosci 1998;20:271-276.
40. Franke C, Brinker G, Pillekamp F, Hoehn M. Probability of metabolic tissue recovery after thrombolytic treatment of experimental stroke: a magnetic resonance spectroscopic imaging study in rat brain. J Cereb Blood Flow Metab 2000;20:583-591. (Pubitemid 30164902)